https://www.research.adra.ac.id/index.php/jbtn <p style="text-align: justify;"><strong>Journal of Biomedical and Techno Nanomaterials</strong> is an international forum for the publication of peer-reviewed integrative review articles, special thematic issues, reflections or comments on previous research or new research directions, interviews, replications, and intervention articles - all pertaining to the research fields of medicine, pharmaceuticals, biomaterials, biotechnology, diagnosis and prevention of diseases, biomedical devices, bioinformatics, and all other related fields of biomedical and life sciences. All publications provide breadth of coverage appropriate to a wide readership in Biomedical and Techno Nanomaterials research depth to inform specialists in that area. We feel that the rapidly growing <strong>Journal of Biomedical and Techno Nanomaterials</strong> community is looking for a journal with this profile that we can achieve together. Submitted papers must be written in English for initial review stage by editors and further review process by minimum two international reviewers.</p> Yayasan Adra Karima Hubbi en-US Journal of Biomedical and Techno Nanomaterials 3048-1120 https://www.research.adra.ac.id/index.php/jbtn/article/view/3211 <p>Pharmaceutical nanotechnology has emerged as a promising approach to enhance the bioavailability and therapeutic efficacy of drugs. Many drugs suffer from poor solubility, limited absorption, and rapid metabolism, leading to suboptimal therapeutic outcomes. Nanotechnology-based drug delivery systems offer solutions to these challenges by improving the stability, solubility, and controlled release of pharmaceuticals. This study explores the use of nanotechnology in the design and development of drug delivery systems aimed at enhancing bioavailability and optimizing therapeutic efficacy. The primary objective is to evaluate the effectiveness of various nanocarriers, including liposomes, dendrimers, and polymeric nanoparticles, in improving drug solubility and ensuring targeted delivery. The research employs in vitro and in vivo models to assess drug release profiles, absorption rates, and pharmacokinetic properties. The results demonstrate that nanotechnology-based systems significantly improve drug bioavailability and extend therapeutic efficacy by providing controlled and sustained drug release, reducing side effects, and enhancing cellular uptake. In conclusion, pharmaceutical nanotechnology offers a powerful strategy to overcome the limitations of conventional drug delivery systems, providing a pathway for more effective treatments in various therapeutic areas.</p> <p>&nbsp;</p> Fatima Ahmed Ali Omar Muntasir Muntasir Copyright (c) 2026 Fatima Ahmed, Ali Omar, Muntasir Muntasir https://creativecommons.org/licenses/by-sa/4.0 2026-04-04 2026-04-04 3 2 86 97 10.70177/jbtn.v3i2.3211